OraPharma, Inc.

Founded in 1996, OraPharma, Inc. is a specialty healthcare company that discovers, develops, and commercializes products that maintain and restore oral health. In 2002, OraPharma, Inc. was acquired by the Johnson & Johnson Family of Companies.

OraPharma, Inc.’s lead product, ARESTIN® (minocycline hydrochloride) Microspheres, 1 mg, is indicated as an adjunct to scaling and root planing (SRP) procedures for the reduction of pocket depth in patients with adult periodontitis. In addition, OraPharma, Inc. distributes HEALOS® (Bone Graft Substitute for Dental Applications) is intended to fill, augment, or reconstruct periodontal and or bony defects of the upper or lower jaw.